Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WRF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,841
Award facts
- Contract value 100% obligated
- $13,840.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ondansetron ODT 4 mg tablets (30-count units) valued at $13,840.52 under a firm fixed-price contract. This is a non-set-aside award with a completion date of December 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings for nausea and vomiting management. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate operations as a major pharmaceutical distributor supporting federal medical procurement.
AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026, which serves as the parent vehicle enabling delivery orders for a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience fulfilling Department of Defense pharmaceutical requirements across multiple therapeutic domains, including specialty medications, generic drugs, and vaccines. This delivery order reflects the company's critical role as a pharmaceutical prime vendor within the DLA Medical Supply Chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded arrangements.
Quick answers
Who was awarded contract SPE2DR26F7WRF?
SPE2DR26F7WRF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F7WRF worth?
The government has obligated $13,841 on SPE2DR26F7WRF.
Is contract SPE2DR26F7WRF an order under another contract?
Yes. SPE2DR26F7WRF is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WRF competed?
The extent of competition for SPE2DR26F7WRF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award